Oncology Cancer Drugs Market Growth at 9. 43% CAGR, Targeting 432. 6 Billion USD by 2032 | Eli Lilly and Company
With a projected revenue of USD 432.6 billion by 2032, the Oncology Cancer Drugs market is experiencing significant growth, driven by a CAGR of 9.43%. LONDON , ENGLAND, UNITED KINGDOM, January 15, 2025 /EINPresswire.com/ -- 𝚆𝙶𝚁 released the …